Tharimmune Inc. (THAR)
Tharimmune Statistics
Share Statistics
Tharimmune has 2.11M shares outstanding. The number of shares has increased by 178.14% in one year.
| Shares Outstanding | 2.11M |
| Shares Change (YoY) | 178.14% |
| Shares Change (QoQ) | 47.12% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 1,152 |
| FTD / Avg. Volume | 0.93% |
Short Selling Information
The latest short interest is 73.53K, so 3.8% of the outstanding shares have been sold short.
| Short Interest | 73.53K |
| Short % of Shares Out | 3.8% |
| Short % of Float | 3.83% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -0.22 and the forward PE ratio is -2.32. Tharimmune's PEG ratio is 0.
| PE Ratio | -0.22 |
| Forward PE | -2.32 |
| PS Ratio | 0 |
| Forward PS | n/a |
| PB Ratio | 2.01 |
| P/FCF Ratio | -0.24 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Tharimmune.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.54, with a Debt / Equity ratio of 0.
| Current Ratio | 1.54 |
| Quick Ratio | 1.54 |
| Debt / Equity | 0 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 908.64 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-6,098,784 |
| Employee Count | 2 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -72.61% in the last 52 weeks. The beta is 1.2, so Tharimmune's price volatility has been higher than the market average.
| Beta | 1.2 |
| 52-Week Price Change | -72.61% |
| 50-Day Moving Average | 1.38 |
| 200-Day Moving Average | 2.2 |
| Relative Strength Index (RSI) | 61.33 |
| Average Volume (20 Days) | 123,927 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -12.43M |
| Net Income | -12.2M |
| EBITDA | -12.43M |
| EBIT | -12.21M |
| Earnings Per Share (EPS) | -9.41 |
Balance Sheet
The company has 3.56M in cash and 0 in debt, giving a net cash position of 3.56M.
| Cash & Cash Equivalents | 3.56M |
| Total Debt | n/a |
| Net Cash | n/a |
| Retained Earnings | -36.9M |
| Total Assets | 3.72M |
| Working Capital | 1.31M |
Cash Flow
In the last 12 months, operating cash flow was -10.9M and capital expenditures 0, giving a free cash flow of -10.9M.
| Operating Cash Flow | -10.9M |
| Capital Expenditures | n/a |
| Free Cash Flow | -10.9M |
| FCF Per Share | -8.41 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
THAR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for THAR is $17, which is 996.8% higher than the current price. The consensus rating is "Buy".
| Price Target | $17 |
| Price Target Difference | 996.8% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Stock Splits
The last stock split was on May 28, 2024. It was a backward split with a ratio of 1:15.
| Last Split Date | May 28, 2024 |
| Split Type | backward |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | -23.64 |
| Piotroski F-Score | 1 |